The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI
Open accessAbstract
BACKGROUND: Coronary revascularization guided by fractional flow reserve (FFR) is associated with better patient outcomes after the procedure than revascularization guided by angiography alone. It is unknown whether the instantaneous wave-free ratio (iFR), an alternative measure that does not require the administration of adenosine, will offer benefits similar to those of FFR. METHODS: We randomly assigned 2492 patients with coronary artery disease, in a 1:1 ratio, to undergo either iFR-guided or FFR-guided coronary revascularization. The primary end point was the 1-year risk of major adverse cardiac events, which were a composite of death from any cause, nonfatal myocardial infarction, or unplanned revascularization. The trial was designed to show the noninferiority of iFR to FFR, with a margin of 3.4 percentage points for the difference in risk. RESULTS: At 1 year, the primary end point had occurred in 78 of 1148 patients (6.8%) in the iFR group and in 83 of 1182 patients (7.0%) in the FFR group (difference in risk, -0.2 percentage points; 95% confidence interval [CI], -2.3 to 1.8; P<0.001 for noninferiority; hazard ratio, 0.95; 95% CI, 0.68 to 1.33; P=0.78). The risk of each component of the primary end point and of death from cardiovascular or noncardiovascular causes did not differ significantly between the groups. The number of patients who had adverse procedural symptoms and clinical signs was significantly lower in the iFR group than in the FFR group (39 patients [3.1%] vs. 385 patients [30.8%], P<0.001), and the median procedural time was significantly shorter (40.5 minutes vs. 45.0 minutes, P=0.001). CONCLUSIONS: Coronary revascularization guided by iFR was noninferior to revascularization guided by FFR with respect to the risk of major adverse cardiac events at 1 year. The rate of adverse procedural signs and symptoms was lower and the procedural time was shorter with iFR than with FFR. (Funded by Philips Volcano; DEFINE-FLAIR ClinicalTrials.gov number, NCT02053038 .).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009638 · Cited by 9,430
Self-citationApixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
(2014) · European Heart Journal · doi:10.1093/eurheartj/ehu278 · Cited by 4,314
Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention
Tonino, P. A. L., De Bruyne, B., Pijls, N. H. J., Siebert, U., Ikeno, F., van `t Veer, M., Klauss, V., Manoharan, G., Engstrøm, T., Oldroyd, K. G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0807611 · Cited by 4,260
Holmes, D. R., Kar, S., Price, M. J., Whisenant, B., Sievert, H., Doshi, S. K., Huber, K., & Reddy, V. Y. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.04.029 · Cited by 1,845
Mohr, F. W., Morice, M.-C., Kappetein, A. P., Feldman, T. E., Ståhle, E., Colombo, A., Mack, M. J., Holmes, D. R., Morel, M.-A., Dyck, N. V., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60141-5 · Cited by 1,789
Self-citationPijls, N. H., van Son, J. A., Kirkeeide, R. L., De Bruyne, B., & Gould, K. L. (1993) · Circulation · doi:10.1161/01.cir.87.4.1354 · Cited by 1,183
Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease
Stone, G. W., Sabik, J. F., Serruys, P. W., Simonton, C. A., Généreux, P., Puskas, J., Kandzari, D. E., Morice, M.-C., Lembo, N., Brown, W. M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1610227 · Cited by 1,068
Self-citationInstantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI
Götberg, M., Christiansen, E. H., Gudmundsdottir, I. J., Sandhall, L., Danielewicz, M., Jakobsen, L., Olsson, S.-E., Öhagen, P., Olsson, H., Omerovic, E., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1616540 · Cited by 985
Mäkikallio, T., Holm, N. R., Lindsay, M., Spence, M. S., Erglis, A., Menown, I. B. A., Trovik, T., Eskola, M., Romppanen, H., Kellerth, T., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)32052-9 · Cited by 772
Self-citationPatel, M. R., Dehmer, G. J., Hirshfeld, J. W., Smith, P. K., & Spertus, J. A. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.12.001 · Cited by 594
Self-citationCoronary flow reserve as a physiologic measure of stenosis severity
Gould, K. L., Kirkeeide, R. L., & Buchi, M. (1990) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)80078-6 · Cited by 548
Cerqueira, M. D., Verani, M. S., Schwaiger, M., Heo, J., & Iskandrian, A. S. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90424-3 · Cited by 464
van de Hoef, T. P., van Lavieren, M. A., Damman, P., Delewi, R., Piek, M. A., Chamuleau, S. A. J., Voskuil, M., Henriques, J. P. S., Koch, K. T., de Winter, R. J., et al. (2014) · Circulation: Cardiovascular Interventions · doi:10.1161/circinterventions.113.001049 · Cited by 372
Self-citationLayland, J., Oldroyd, K. G., Curzen, N., Sood, A., Balachandran, K., Das, R., Junejo, S., Ahmed, N., Lee, M. M. Y., Shaukat, A., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu338 · Cited by 321
von Birgelen, C., Basalus, M. W. Z., Tandjung, K., van Houwelingen, K. G., Stoel, M. G., Louwerenburg, J. (. W., Linssen, G. C. M., Saïd, S. A. M., Kleijne, M. A. W. J., Sen, H., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.01.008 · Cited by 250
Sen, S., Asrress, K. N., Nijjer, S., Petraco, R., Malik, I. S., Foale, R. A., Mikhail, G. W., Foin, N., Broyd, C., Hadjiloizou, N., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.01.034 · Cited by 233
Self-citationEscaned, J., Echavarría-Pinto, M., Garcia-Garcia, H. M., van de Hoef, T. P., de Vries, T., Kaul, P., Raveendran, G., Altman, J. D., Kurz, H. I., Brechtken, J., et al. (2015) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2015.01.029 · Cited by 203
Self-citationPetraco, R., van de Hoef, T. P., Nijjer, S., Sen, S., van Lavieren, M. A., Foale, R. A., Meuwissen, M., Broyd, C., Echavarria-Pinto, M., Foin, N., et al. (2014) · Circulation: Cardiovascular Interventions · doi:10.1161/circinterventions.113.000926 · Cited by 166
Self-citationPatel, M. R., DEHMER, G. J., Hirshfeld, J. W., Smith, P. K., Spertus, J. A., Masoudi, F. A., DEHMER, G. J., Patel, M. R., Smith, P. K., Chambers, C. E., et al. (2012) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2012.01.061 · Cited by 117
Self-citationFearon, W. F., Shilane, D. A., Pijls, N. H. J., Boothroyd, D. B., Tonino, P. A. L., Barbato, E., Jüni, P., Bruyne, B. D., & Hlatky, M. A. (2013) · Circulation · doi:10.1161/circulationaha.113.003059 · Cited by 99
Proarrhythmic effects of adenosine: a review of the literature
Mallet, M. (2004) · Emergency Medicine Journal · doi:10.1136/emj.2004.016048 · Cited by 68
Dilsizian, V., Gewirtz, H., Paivanas, N., Kitsiou, A. N., Hage, F. G., Crone, N. E., & Schwartz, R. G. (2015) · Journal of Nuclear Cardiology · doi:10.1007/s12350-015-0141-4 · Cited by 47
Cited by
2018 ESC/EACTS guidelines on myocardial revascularization
Neumann, F.-J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy394 · Cited by 7,167
Collet, J.-P., Thiele, H., Barbato, E., Barthélémy, O., Bauersachs, J., Bhatt, D. L., Dendale, P., Dorobantu, M., Edvardsen, T., Folliguet, T., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa575 · Cited by 5,037
Self-citation2024 ESC Guidelines for the management of chronic coronary syndromes
Vrints, C., Andreotti, F., Koskinas, K. C., Rossello, X., Adamo, M., Ainslie, J., Banning, A. P., Budaj, A., Buechel, R. R., Chiariello, G. A., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae177 · Cited by 2,774
Self-citationVirani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001168 · Cited by 1,598
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization
Lawton, J. S., Tamis-Holland, J. E., Bangalore, S., Bates, E. R., Beckie, T. M., Bischoff, J. M., Bittl, J. A., Cohen, M. G., DiMaio, J. M., Don, C. W., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.09.006 · Cited by 1,558
Metadata
- Authors
- Davies, J. E., Sen, S., Dehbi, H.-M., Al-Lamee, R., Petraco, R., Nijjer, S. S., Bhindi, R., Lehman, S. J., Walters, D., Sapontis, J., Janssens, L., Vrints, C. J., Khashaba, A., Laine, M., Van Belle, E., Krackhardt, F., Bojara, W., Going, O., Härle, T., Indolfi, C., Niccoli, G., Ribichini, F., Tanaka, N., Yokoi, H., Takashima, H., Kikuta, Y., Erglis, A., Vinhas, H., Canas Silva, P., Baptista, S. B., Alghamdi, A., Hellig, F., Koo, B.-K., Nam, C.-W., Shin, E.-S., Doh, J.-H., Brugaletta, S., Alegria-Barrero, E., Meuwissen, M., Piek, J. J., van Royen, N., Sezer, M., Di Mario, C., Gerber, R. T., Malik, I. S., Sharp, A. S. P., Talwar, S., Tang, K., Samady, H., Altman, J., Seto, A. H., Singh, J., Jeremias, A., Matsuo, H., Kharbanda, R. K., Patel, M. R., Serruys, P., & Escaned, J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2017-05-11
- Volume
- 376
- Issue
- 19
- Pages
- 1824-1834
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2597278873
- Cited by
- 979
- References
- 23
- FWCI
- 109.16
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.